1. Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents
   Eleni Sflakidou et al, 2022, Molecules CrossRef
2. Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53
   Maria Mrakovcic et al, 2018, International Journal of Molecular Sciences CrossRef
3. Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors
   Martin Haefner et al, 2008, World Journal of Gastroenterology CrossRef
4. It's About Time: Scheduling Alters Effect of Histone Deacetylase Inhibitors on Camptothecin-Treated Cells
   Robert L. Bevins et al, 2005, Cancer Research CrossRef
5. HDAC inhibitors: applications in oncology and beyond
   Omika Katoch et al, 2013, HOAJ Biology CrossRef
6. p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death
   Maria Mrakovcic et al, 2019, International Journal of Molecular Sciences CrossRef
7. Regulation of HDACi−Triggered Autophagy by the Tumor Suppressor Protein p53
   Maria Mrakovcic et al, 2019, Genes and Cancer CrossRef
8. Antitumor Effects of a Novel Phenylbutyrate-Based Histone Deacetylase Inhibitor, (S)-HDAC-42, in Prostate Cancer
   Samuel K. Kulp et al, 2006, Clinical Cancer Research CrossRef
9. The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors
   Fangyuan Cao et al, 2018, Molecules CrossRef